Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2014 7
2015 11
2016 15
2017 25
2018 14
2019 26
2020 39
2021 56
2022 67
2023 60
2024 64
2025 74
2026 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean imone ribero (1 results)?
Dupilumab-induced Urticaria.
Mastorino L, Ortoncelli M, Virginia B, Rolla G, Avallone G, Cavaliere G, Riccardo V, Quaglino P, Ribero S. Mastorino L, et al. Among authors: ribero s. Dermatol Ther. 2021 Nov;34(6):e15117. doi: 10.1111/dth.15117. Epub 2021 Sep 6. Dermatol Ther. 2021. PMID: 34459079 No abstract available.
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study.
Torres T, Yeung J, Prajapati V, Ribero S, Balato A, Valerio Marzano A, Cruz MJ, Paiva Lopes MJ, Lazaridou E, Carrascosa JM, Alvarenga JM, Farinha P, Duarte B, Sood S, Rankin BD, Ortoncelli M, Caccavale S, Ferrucci SM, Rosa GP, Daponte AI, Silvi G, Peris K, Gori N, Herranz P, Prignano F, Kolios A, Rompoti N, Gkalpakiotis S, Chiricozzi A. Torres T, et al. Among authors: ribero s. J Eur Acad Dermatol Venereol. 2025 Sep;39(9):e756-e761. doi: 10.1111/jdv.20581. Epub 2025 Feb 6. J Eur Acad Dermatol Venereol. 2025. PMID: 39912554 No abstract available.
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study.
Barei F, Macchi S, Calzari P, Ribero S, Ortoncelli M, Foti C, Balato A, Di Brizzi EV, Peris K, Gori N, Ippoliti E, Gurioli C, Piraccini BM, Trave I, Cozzani E, Pezzolo E, Bonzano L, Errichetti E, Schettini N, Nettis E, Gola M, Milanesi N, Feliciani C, De Felici Del Giudice MB, Campanati A, Gioacchini H, Pisapia A, Avallone G, Micali G, Musumeci ML, Ortega R, Manzo Margiotta F, Romanelli M, Hansel K, Stingeni L, Patruno C, Esposito M, Fargnoli MC, De Berardinis A, Ferreli C, Calabrese L, Rubegni P, Lazzeri L, Grigolato L, Galli B, Rossi M, Maurelli M, Girolomoni G, Lauletta G, Napolitano M, Alfano A, Gargiulo L, Narcisi A, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: ribero s. Clin Exp Dermatol. 2025 Oct 27;50(11):2221-2231. doi: 10.1093/ced/llaf275. Clin Exp Dermatol. 2025. PMID: 40578600
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
Avallone G, Maronese CA, Zussino M, Muratori S, Ferrucci SM, Quaglino P, Manni E, Romanelli M, De Simone C, Foti C, Gargiulo L, Maione V, Calzavara-Pinton P, Bardazzi F, Piraccini BM, Antiga E, Rech G, Balestri R, Vezzoli P, Sena P, Esposito M, Fargnoli MC, Termini D, Valtellini L, Satta RR, Vassallo C, Provini A, Di Zenzo G, Campanati A, Caproni M, Cozzani E, Ribero S, Marzano AV; DUO—DUpilumab and Omalizumab in Bullous Pemphigoid Study Group. Avallone G, et al. Among authors: ribero s. J Dermatol. 2025 Jun;52(6):983-1000. doi: 10.1111/1346-8138.17742. Epub 2025 Apr 16. J Dermatol. 2025. PMID: 40237419 Free article.
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years.
Chovatiya R, Ribero S, Wollenberg A, Park CO, Silvestre JF, Hong HC, Seneschal J, Saeki H, Thyssen JP, Øland CB, Gjerum L, Maslin D, Blauvelt A. Chovatiya R, et al. Among authors: ribero s. Am J Clin Dermatol. 2025 Jul;26(4):587-601. doi: 10.1007/s40257-025-00931-1. Epub 2025 Mar 14. Am J Clin Dermatol. 2025. PMID: 40085349 Free PMC article. Clinical Trial.
Omics Landscape in Disease Biomarkers Discovery.
Neagu M, Longo C, Ribero S. Neagu M, et al. Among authors: ribero s. Dis Markers. 2016;2016:4068252. doi: 10.1155/2016/4068252. Epub 2016 Oct 24. Dis Markers. 2016. PMID: 27843174 Free PMC article. No abstract available.
Ruta graveolens phytophotodermatitis.
Avallone G, Mastorino L, Agostini A, Merli M, Siliquini N, Rubatto M, Fierro MT, Ribero S, Quaglino P. Avallone G, et al. Among authors: ribero s. Dermatol Online J. 2021 Jul 15;27(7). doi: 10.5070/D327754382. Dermatol Online J. 2021. PMID: 34391344 Free article. No abstract available.
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes.
Barei F, Calzari P, Pezzolo E, Napolitano M, Rossi M, Guanti MB, Caroppo F, Belloni Fortina A, Patruno C, Campanati A, Bianchelli T, D'Agostino GM, Nettis E, Pugliese F, di Vico F, Trave I, Cozzani E, Stingeni L, Hansel K, Dall'Olio M, Grigolato L, Coppola R, Panasiti V, Maurelli M, Girolomoni G, Ortoncelli M, Ribero S, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: ribero s. J Clin Med. 2025 Mar 18;14(6):2077. doi: 10.3390/jcm14062077. J Clin Med. 2025. PMID: 40142885 Free PMC article.
Treatment of Lichen Planopilaris With Abrocitinib.
Gallo G, Ribero S, Ortoncelli M, Valtellini L, Marzano AV, Quaglino P, Avallone G. Gallo G, et al. Among authors: ribero s. Int J Dermatol. 2025 Aug;64(8):1497-1498. doi: 10.1111/ijd.17681. Epub 2025 Feb 9. Int J Dermatol. 2025. PMID: 39923193 No abstract available.
409 results